A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.
CONCLUSIONS: Universal TXA was associated with a reduction of RBC transfusion, overall and in clinically relevant subgroups, strengthening the rationale for universal therapy.
PMID: 30383292 [PubMed - as supplied by publisher]
Source: Transfusion - Category: Hematology Authors: Pavenski K, Ward SE, Hare GMT, Freedman J, Pulendrarajah R, Pirani RA, Sheppard N, Vance C, White A, Lo N, Waddell JP, Ho A, Schemitsch EH, Kataoka M, Bogoch ER, Saini K, David Mazer C, Baker JE Tags: Transfusion Source Type: research
More News: Anemia | Heart Attack | Pulmonary Thromboembolism | Stroke | Study | Thrombosis | Urology & Nephrology